Literature DB >> 29395334

Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.

Vidar T N Stefansson1, Jørgen Schei2, Marit D Solbu3, Trond G Jenssen4, Toralf Melsom3, Bjørn O Eriksen3.   

Abstract

Rapid age-related glomerular filtration rate (GFR) decline increases the risk of end-stage renal disease, and a low GFR increases the risk of mortality and cardiovascular disease. High body mass index and the metabolic syndrome are well-known risk factors for patients with advanced chronic kidney disease, but their role in accelerating age-related GFR decline independent of cardiovascular disease, hypertension and diabetes is not adequately understood. We studied body mass index, waist circumference, waist-hip ratio and metabolic syndrome as risk factors for accelerated GFR decline in 1261 middle-aged people representative of the general population without diabetes, cardiovascular disease or kidney disease. GFR was measured as iohexol clearance at baseline and repeated after a median of 5.6 years. Metabolic syndrome was defined as fulfilling three out of five criteria, based on waist circumference, blood pressure, glucose, high-density lipoprotein cholesterol and triglycerides. The mean GFR decline rate was 0.95 ml/min/year. Neither the body mass index, waist circumference nor waist-hip ratio predicted statistically significant changes in age-related GFR decline, but individuals with baseline metabolic syndrome had a significant mean of 0.30 ml/min/year faster decline than individuals without metabolic syndrome in a multivariable adjusted linear regression model. This association was mainly driven by the triglyceride criterion of metabolic syndrome, which was associated with a significant 0.36 ml/min/year faster decline when analyzed separately. Results differed significantly when GFR was estimated using creatinine and/or cystatin C. Thus, metabolic syndrome, but not the body mass index, waist circumference or waist-hip ratio, is an independent risk factor for accelerated age-related GFR decline in the general population.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  glomerular filtration rate; metabolic syndrome; obesity; triglycerides

Mesh:

Substances:

Year:  2018        PMID: 29395334     DOI: 10.1016/j.kint.2017.11.012

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Urinary excretion of epidermal growth factor and rapid loss of kidney function.

Authors:  Jon Viljar Norvik; Laura R Harskamp; Viji Nair; Kerby Shedden; Marit D Solbu; Bjørn O Eriksen; Matthias Kretzler; Ron T Gansevoort; Wenjun Ju; Toralf Melsom
Journal:  Nephrol Dial Transplant       Date:  2021-09-27       Impact factor: 5.992

2.  Incidence of and risk factors of chronic kidney disease: results of a nationwide study in Iceland.

Authors:  Arnar J Jonsson; Sigrun H Lund; Bjørn O Eriksen; Runolfur Palsson; Olafur S Indridason
Journal:  Clin Kidney J       Date:  2022-02-25

3.  Association of Body Mass Index and Waist Circumference with All-Cause Mortality in Hemodialysis Patients.

Authors:  Chang Seong Kim; Kyung-Do Han; Hong Sang Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

4.  Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care.

Authors:  Luma de O Comini; Laura C de Oliveira; Luiza D Borges; Heloísa H Dias; Clara R S Batistelli; Luciana S da Silva; Tiago R Moreira; Rodrigo G da Silva; Rosângela M M Cotta
Journal:  Diabetes Metab Syndr Obes       Date:  2020-01-09       Impact factor: 3.168

5.  Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study.

Authors:  Eun Sil Koh; Kyung Do Han; Mee Kyoung Kim; Eun Sook Kim; Min-Kyung Lee; Ga Eun Nam; Oak-Kee Hong; Hyuk-Sang Kwon
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

Review 6.  Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach.

Authors:  Pei-Chin Lin; Chu-Lin Chou; Shih-Hsiang Ou; Te-Chao Fang; Jin-Shuen Chen
Journal:  Nutrients       Date:  2021-01-30       Impact factor: 5.717

7.  Association of High-Density Lipoprotein Cholesterol With GFR Decline in a General Nondiabetic Population.

Authors:  Toralf Melsom; Jon Viljar Norvik; Inger Therese Enoksen; Vidar Stefansson; Renathe Rismo; Trond Jenssen; Marit D Solbu; Bjørn O Eriksen
Journal:  Kidney Int Rep       Date:  2021-05-19

8.  Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.

Authors:  Melissa Soohoo; Leila Hashemi; Jui-Ting Hsiung; Hamid Moradi; Matthew J Budoff; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Nephron       Date:  2022-03-30       Impact factor: 3.457

9.  Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV-Risk Study.

Authors:  Marit D Solbu; Atena Miroslawska; Jon V Norvik; Bjørn O Eriksen; Terje K Steigen
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-16       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.